Brief: Lee's Pharmaceutical Says Unit's Nadroparin Calcium For Injection Obtained Drug Registration Approval
06/08/2020 12:46
Aug 6 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UNIT'S NADROPARIN CALCIUM FOR INJECTION OBTAINED DRUG
REGISTRATION APPROVAL FROM NMPA
Source text for Eikon: ID:nHKSb7SKJt
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals